首页 >
法规速递
-
Page: Clinical evaluation of medicinal products intended for treatment of hepatitis B - Scientific guideline-2025/9/30
2025-10-08查看详情 > -
Page: Union Product Database: release notes-2025/11/7
2025-11-10查看详情 > -
Page: Substance and product data management services-2025/12/8
2025-12-09查看详情 > -
Document: Minutes - PDCO minutes of the 11-14 November 2025 meeting-2026/1/15
2026-01-16查看详情 > -
国家药监局药审中心关于发布《新药全球同步研发中基于多区域临床试验数据进行获益-风险评估的指导原则（试行）》的通告（2026年第18号）-2026/2/24
2026-02-27查看详情 > -
Document: List of medicinal products under additional monitoring-2026/3/25
2026-03-26查看详情 > -
Page: Class III implantable devices and Class IIb medical devices intended to administer or remove medicinal products: expert panel opinions-2026/4/29
2026-04-30查看详情 > -
Page: Substance and product data management services-2026/6/12
2026-06-15查看详情 > -
国家药监局综合司公开征求《化学原料药登记主体变更管理规定（征求意见稿）》意见-2026/7/23
2026-07-24查看详情 > -
Information Requests and Discipline Review Letters Under the Generic Drug User Fee Amendments (Final)-2022/10/5
2022-11-15查看详情 >
